WALL STREET ASSOCIATES - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 48 filers reported holding NEOS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WALL STREET ASSOCIATES ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$983,000
-29.1%
149,3430.0%0.34%
-39.5%
Q2 2016$1,386,000
-14.0%
149,3430.0%0.55%
-17.2%
Q1 2016$1,611,000
-24.7%
149,3430.0%0.67%
+11.1%
Q4 2015$2,139,000
-48.9%
149,343
-25.1%
0.60%
-24.8%
Q3 2015$4,188,000199,3430.80%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,858,889$7,337,0005.11%
Proxima Capital Management, LLC 170,294$257,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 3,530,731$5,331,0000.44%
Nantahala Capital Management 4,610,000$6,961,0000.21%
Wealthstar Advisors, LLC 73,295$111,0000.07%
Alambic Investment Management, L.P. 51,733$78,0000.06%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$151,0000.05%
BCS Wealth Management 29,520$45,0000.03%
Allred Capital Management, LLC 24,995$37,742,0000.02%
ALGERT GLOBAL LLC 34,254$52,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders